Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prem P Batchala

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
World Neurosurgery|December 15, 2021
Predicting Functional Outcome After Decompressive Craniectomy for Malignant Hemispheric Infarction: Clinical and Novel Imaging FactorsAskiel Bruno, Nina Paletta, Uttam Verma, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 4, 2021
Limiting Brain Shift in Malignant Hemispheric Infarction by Decompressive CraniectomyAskiel Bruno, Nina Paletta, Uttam Verma, et al.
Journal of Neuro-Oncology|March 4, 2021
Fluid attenuation in non-contrast-enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in GlioblastomaSohil H Patel, Prem P Batchala, Thomas J Eluvathingal Muttikkal, et al.
Journal of Neuro-Oncology|January 21, 2026
Magnetic resonance imaging features differentiate histologic and molecular subtypes of glioblastoma IDH-Wild type CNS WHO grade 4Sohil H Patel, Shanna Mayorov, Wooil Kim, et al.
Journal of Neuro-Oncology|September 10, 2020
Automated apparent diffusion coefficient analysis for genotype prediction in lower grade glioma: association with the T2-FLAIR mismatch signEric Aliotta, Sunil W Dutta, Xue Feng, et al.
Radiology|November 13, 2019
MRI and CT Identify Isocitrate Dehydrogenase <i>(IDH)</i>-Mutant Lower-Grade Gliomas Misclassified to 1p/19q Codeletion Status with Fluorescence in Situ HybridizationSohil H Patel, Prem P Batchala, E Kelly S Mrachek, et al.
Neuroradiology|August 11, 2022
MRI features predict tumor grade in isocitrate dehydrogenase (IDH)-mutant astrocytoma and oligodendrogliomaDavid A Joyner, John Garrett, Prem P Batchala, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 19, 2019
Cerebellar syndrome in a man treated with natalizumab: From the National Multiple Sclerosis Society Case Conference ProceedingsDavid A Lapides, Prem P Batchala, Joseph H Donahue, et al.
Head & Neck|February 23, 2024
Oncocytic carcinoma of the thyroid: Conclusions from a 20-year patient cohortNelson R Gruszczynski, Shahzeb S Hasan, Ana G Brennan, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
World Neurosurgery|December 15, 2021
Predicting Functional Outcome After Decompressive Craniectomy for Malignant Hemispheric Infarction: Clinical and Novel Imaging FactorsAskiel Bruno, Nina Paletta, Uttam Verma, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 4, 2021
Limiting Brain Shift in Malignant Hemispheric Infarction by Decompressive CraniectomyAskiel Bruno, Nina Paletta, Uttam Verma, et al.
Journal of Neuro-Oncology|March 4, 2021
Fluid attenuation in non-contrast-enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in GlioblastomaSohil H Patel, Prem P Batchala, Thomas J Eluvathingal Muttikkal, et al.
Journal of Neuro-Oncology|January 21, 2026
Magnetic resonance imaging features differentiate histologic and molecular subtypes of glioblastoma IDH-Wild type CNS WHO grade 4Sohil H Patel, Shanna Mayorov, Wooil Kim, et al.
Journal of Neuro-Oncology|September 10, 2020
Automated apparent diffusion coefficient analysis for genotype prediction in lower grade glioma: association with the T2-FLAIR mismatch signEric Aliotta, Sunil W Dutta, Xue Feng, et al.
Radiology|November 13, 2019
MRI and CT Identify Isocitrate Dehydrogenase <i>(IDH)</i>-Mutant Lower-Grade Gliomas Misclassified to 1p/19q Codeletion Status with Fluorescence in Situ HybridizationSohil H Patel, Prem P Batchala, E Kelly S Mrachek, et al.
Neuroradiology|August 11, 2022
MRI features predict tumor grade in isocitrate dehydrogenase (IDH)-mutant astrocytoma and oligodendrogliomaDavid A Joyner, John Garrett, Prem P Batchala, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 19, 2019
Cerebellar syndrome in a man treated with natalizumab: From the National Multiple Sclerosis Society Case Conference ProceedingsDavid A Lapides, Prem P Batchala, Joseph H Donahue, et al.
Head & Neck|February 23, 2024
Oncocytic carcinoma of the thyroid: Conclusions from a 20-year patient cohortNelson R Gruszczynski, Shahzeb S Hasan, Ana G Brennan, et al.
Pageof 3